1Murphy S,Peteron P,Iland H,et al.Experience of the Polycythe mia Vera Study Group with essential thrombocythe mia:a final report on diagnostic criteria,survival,and leuke mia transition by treat ment.Semin He matol,1997;34(1):29.
1Murphy S, Peterson P,Iland H, et al. Experience of the Polycythemia Vera StudyGroup with essential thrombocythemia：a final report on diagnostic criteria,survival,andleukemic transition by treatment .Semin Hematol,1997,34：29～39
2Basses C, Cervantes F, Pereira A, et al. Major vascular complications in essentialthrombocythemia：a study of the predictive factors in a series of 148 patients.Leukemia,1999,13：150～154
3Sterkers Y, Preudhomme C,Lai JL, et al. Acute myeloid leukemia and myelodysplasticsyndromes following essential thrombocythaemia treated with hydroxyura：high proportionof cases with 17p deletion. Blood,1998,91：616～622
4Barbui T, Finazzi G, Dupuy E, et al. Treatment strategies in essentialthrombocythemia：a critical appraisal of various experiences in different centers.Leukemia and Lymphoma,1996,22(Suppl 1)：149～160
收稿 1999-03-30
修回 1999-09-10
5Akca S, Haji-Michael P, Mendonca A, et al. The time course of platelet counts in critically ill patilents. Crit Care Med, 2002,30 (4) :75.
6Ishiguro A, Suzuki Y, Mito M, et al. Elevation of serum thrombopoi- etin precedes thrombocytosis in acute infections. Br J Haematol, 2002,116(3) :612-618.
